Abiopharma

🔍 Gillespie Charles (Executive)

Company: Gambling.com Group Ltd (GAMB)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 20,919 shares of Ordinary Shares at $3.72 per share (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 200,024.00 | transaction_form_type: 4
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Praetorium Limited | shares_owned_after: 3,718,176.00 | Footnotes: F1
• Sold 20,919 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 131,027.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: Mr. Gillespie controls voting, dispositive and investment power with respect to the ordinary shares held by Praetorium Limited and therefore may be deemed to beneficially own the ordinary shares held by Praetorium Limited.
• F2: Restricted stock units converted into common stock on a one-for-one basis.